Francine Hehn de Oliveira

Author

Universidade Federal do Rio Grande do Sul ORCID

Also Known As

F. H. Oliveira, F. H. de Oliveira, F.H. de Oliveira, Francine H. De Oliveira, Francine H. Oliveira, Francine H. de Oliveira, Francine Hehn Oliveira, Francine Hehn de Oliveira, Francine Oliveira, FrancineHehn Oliveira

Publications

774

Citations

H-Index

Concepts

All Affiliations

Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Universidade Federal de Ciências da Saúde de Porto Alegre Universidade Regional Integrada do Alto Uruguai e das Missões Université Laval

About

Francine Hehn de Oliveira is an author at Universidade Federal do Rio Grande do Sul specializing in medicine, pharmacology, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	430
2	Health Sciences	2	2	39
3	Engineering	1	1	46
4	Social Sciences	1	1	22
5	Biochemistry	1	1	12

Francine Hehn de Oliveira

Publications

702

Citations

H-Index

Page 1

	Year	Citations
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, Molecular Neurobiology	2019	96
CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth Juliana H. Azambuja, Nicolly Espíndola Gelsleichter, Liziane Raquel Beckenkamp, Molecular Neurobiology Neuro-oncologyMedicineImmunologyCd73 Downregulation DecreasesCell Proliferation	2018	90
Geographic and age variations in mutational processes in colorectal cancer Marcos Díaz‐Gay, Wellington dos Santos, Sarah Moody, Nature	2025	64
Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection Jordana Miranda de Souza Silva, Paulo Vinícius Gil Alabarse, Vivian de Oliveira Nunes Teixeira, PLoS ONE Musculoskeletal ScienceEngineeringOrthopedic BiomechanicsOrthopaedic SurgeryMusculoskeletal Research	2018	46
Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme Natália Pontes Bona, Nathália Stark Pedra, Juliana H. Azambuja, Metabolic Brain Disease Glioblastoma MultiformeGliomaMedicinePreclinical ModelOncogenic Agent	2019	42
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, Cancer Chemotherapy and Pharmacology Neuro-oncologyGliomaGlioblastoma Preclinical ModelMedicineImmunology	2020	33
In vivo intracerebral administration of L-2-hydroxyglutaric acid provokes oxidative stress and histopathological alterations in striatum and cerebellum of adolescent rats Mateus Struecker da Rosa, César Augusto João Ribeiro, Bianca Seminotti, Free Radical Biology and Medicine MedicineLipid PeroxidationNeuropharmacologyAdolescent RatsNeuroprotection	2015	30
Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth Emilly S. Villodre, Karina Bettega Felipe, Mayumi Zanotta Oyama, Biochemical and Biophysical Research Communications	2019	28
Ecto-5’-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma Model Angélica Regina Cappellari, Micheli Mainardi Pillat, Hellio D. N. Souza, PLoS ONE	2015	25
Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model Eduarda Correa Freitas, Thaís Evelyn Karnopp, Jordana Miranda de Souza Silva, Autoimmunity ImmunologyRenal InflammationPristane-induced Lupus ModelImmune DysregulationInflammation	2019	24

Page 1